These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transthyretin Amyloidosis with Gastrointestinal Manifestation: a Case Report. Nakov R; Sarafov S; Nakov V; Gospodinova M; Todorov T; Kirov A; Todorova A; Tournev I J Gastrointestin Liver Dis; 2019 Sep; 28(3):359-361. PubMed ID: 31517333 [TBL] [Abstract][Full Text] [Related]
3. THAOS: gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease. Wixner J; Mundayat R; Karayal ON; Anan I; Karling P; Suhr OB; Orphanet J Rare Dis; 2014 Apr; 9():61. PubMed ID: 24767411 [TBL] [Abstract][Full Text] [Related]
4. Founder effect of the Glu89Gln Kirov A; Sarafov S; Pavlova Z; Todorov T; Chamova T; Gospodinova M; Tournev I; Mitev V; Todorova A Amyloid; 2019 Dec; 26(4):181-185. PubMed ID: 31353960 [TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal Manifestations in Hereditary Transthyretin Amyloidosis: a Single-Centre Experience. Luigetti M; Tortora A; Romano A; Di Paolantonio A; Guglielmino V; Bisogni G; Gasbarrini A; Calabresi P; Sabatelli M J Gastrointestin Liver Dis; 2020 Sep; 29(3):339-343. PubMed ID: 32919418 [TBL] [Abstract][Full Text] [Related]
6. Impact of serotonin transporter and catechol-O-methyl transferase genes polymorphism on gastrointestinal dysfunction in Swedish and Japanese familial amyloidotic polyneuropathy patients. Obayashi K; Olsson M; Anan I; Ueda M; Nakamura M; Okamoto S; Yamashita T; Miida T; Ando Y; Suhr OB Clin Chim Acta; 2008 Dec; 398(1-2):10-4. PubMed ID: 18760272 [TBL] [Abstract][Full Text] [Related]
7. Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis. Wixner J; Sundström T; Karling P; Anan I; Suhr OB BMC Gastroenterol; 2015 Apr; 15():51. PubMed ID: 25908211 [TBL] [Abstract][Full Text] [Related]
8. Management of gastrointestinal complications in hereditary transthyretin amyloidosis: a single-center experience over 40 years. Wixner J; Suhr OB; Anan I Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):73-81. PubMed ID: 29073801 [TBL] [Abstract][Full Text] [Related]
9. Cardiac involvement, morbidity and mortality in hereditary transthyretin amyloidosis because of p.Glu89Gln mutation. Gospodinova M; Sarafov S; Chamova T; Kirov A; Todorov T; Nakov R; Todorova A; Denchev S; Tournev I J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):688-695. PubMed ID: 32740500 [TBL] [Abstract][Full Text] [Related]
10. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Coelho T; Maurer MS; Suhr OB Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944 [TBL] [Abstract][Full Text] [Related]
11. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings. Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367 [TBL] [Abstract][Full Text] [Related]
12. Prevalence, Incidence, and Impact on Mortality of Conduction System Disease in Transthyretin Cardiac Amyloidosis. Donnellan E; Wazni OM; Saliba WI; Hanna M; Kanj M; Patel DR; Wilner B; Kochar A; Jaber WA Am J Cardiol; 2020 Aug; 128():140-146. PubMed ID: 32650908 [TBL] [Abstract][Full Text] [Related]
13. Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases. Beirão JM; Malheiro J; Lemos C; Beirão I; Costa P; Torres P Amyloid; 2015; 22(2):117-22. PubMed ID: 26096568 [TBL] [Abstract][Full Text] [Related]
14. Severe chronic diarrhoea caused by hereditary transthyretin amyloidosis. Toppeta A; Dell'Era A; Molteni P; Ardizzone S BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37844979 [TBL] [Abstract][Full Text] [Related]
15. Hereditary ATTR amyloidosis: a single-institution experience with 266 patients. Swiecicki PL; Zhen DB; Mauermann ML; Kyle RA; Zeldenrust SR; Grogan M; Dispenzieri A; Gertz MA Amyloid; 2015; 22(2):123-31. PubMed ID: 26017327 [TBL] [Abstract][Full Text] [Related]
16. Variable Presentation of Hereditary Transthyretin-Mediated Amyloidosis at a Single Center. Hussain Y J Clin Neuromuscul Dis; 2021 Sep; 23(1):7-17. PubMed ID: 34431796 [TBL] [Abstract][Full Text] [Related]
17. Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease. Buades-Reinés J; Raya-Cruz M; Gallego-Lezaún C; Ripoll-Vera T; Usón-Martín M; Andreu-Serra H; Cisneros-Barroso E J Peripher Nerv Syst; 2016 Dec; 21(4):352-356. PubMed ID: 27403623 [TBL] [Abstract][Full Text] [Related]
19. Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience. Lim AY; Lee JH; Jung KS; Gwag HB; Kim DH; Kim SJ; Lee GY; Kim JS; Kim HJ; Lee SY; Lee JE; Jeon ES; Kim K Korean J Intern Med; 2015 Jul; 30(4):496-505. PubMed ID: 26161016 [TBL] [Abstract][Full Text] [Related]
20. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey). Maurer MS; Hanna M; Grogan M; Dispenzieri A; Witteles R; Drachman B; Judge DP; Lenihan DJ; Gottlieb SS; Shah SJ; Steidley DE; Ventura H; Murali S; Silver MA; Jacoby D; Fedson S; Hummel SL; Kristen AV; Damy T; Planté-Bordeneuve V; Coelho T; Mundayat R; Suhr OB; Waddington Cruz M; Rapezzi C; J Am Coll Cardiol; 2016 Jul; 68(2):161-72. PubMed ID: 27386769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]